Open Scanner

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Centogene B V

CNTG
Current price
1.23 USD -0.042 USD (-3.29%)
Last closed 1.27 USD
Sector Healthcare
Industry Diagnostics & Research
Exchange NASDAQ
Capitalization 33 438 962 USD
Yield for 12 month +71.43 %
Week
Month
Year
CNTG
21.11.2021 - 28.11.2021

Centogene N.V., together with its subsidiaries, engages in the research and development of products for human genetics in Europe, the Middle East, North America, Latin America, and the Asia Pacific. It provides data-driven answers to patients, physicians, and pharmaceutical companies for rare and neurodegenerative diseases. It operates through two segments: Pharmaceutical and Diagnostics. The company provides target and drug screening, clinical development, market access and expansion, as well as CENTOGENE Biodatabank licenses and insight report services. In addition, it offers various services, including early patient recruitment and identification, epidemiological insights, biomarker discovery, and patient monitoring; and genetic sequencing and diagnostics services to physicians, laboratories, or hospitals directly or through distributors. Centogene N.V. was founded in 2006 and is headquartered in Rostock, Germany. Address: Am Strande 7, Rostock, Germany, 18055

Analytics

WallStreet Target Price

1.51 USD

P/E ratio

Dividend Yield

Current Year

+51 981 285 USD

Last Year

+207 959 083 USD

Current Quarter

+12 261 421 USD

Last Quarter

+11 307 706 USD

Current Year

+21 637 608 USD

Last Year

+30 832 031 USD

Current Quarter

+5 049 980 USD

Last Quarter

+4 245 180 USD

Key Figures CNTG

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -33 095 000 USD
Operating Margin TTM -86.31 %
PE Ratio
Return On Assets TTM -27.61 %
PEG Ratio
Return On Equity TTM -1375.33 %
Wall Street Target Price 1.51 USD
Revenue TTM 50 708 000 USD
Book Value -0.55 USD
Revenue Per Share TTM 1.85 USD
Dividend Share
Quarterly Revenue Growth YOY 11.3 %
Dividend Yield
Gross Profit TTM 35 904 000 USD
Earnings Share -1.58 USD
Diluted Eps TTM -1.58 USD
Most Recent Quarter II 2022
Quarterly Earnings Growth YOY
Profit Margin -77.64 %

Dividend Analytics CNTG

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History CNTG

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date

Stock Valuation CNTG

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 0.133
Price Sales TTM 0.1281
Enterprise Value EBITDA -1.2306
Price Book MRQ 0.5904

Financials CNTG

1 year
3 years
5 years
10 years
Results 2019 Dynamics

Technical indicators CNTG

For 52 weeks

0.61 USD 1.98 USD
50 Day MA 1.12 USD
Shares Short Prior Month 59 054
200 Day MA 1.02 USD
Short Ratio 1.28
Shares Short 58 229
Short Percent 0.49 %